APA (7th ed.) Citation

Nedogoda, S. V., Ledyaeva, A. A., Chumachek, E. V., Tsoma, V. V., Salasyuk, A. S., Lutova, V. O., . . . Evdokimov, K. S. Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Nedogoda, S. V., et al. Optimization of Blood Pressure Control, Organ Protection and Metabolic Disorders Using a Fixed-dose Combination of Lisinopril+amlodipine+rosuvastatin in Hypertensive Patients After COVID-19. «FIRMA «SILICEA» LLC.

MLA (9th ed.) Citation

Nedogoda, S. V., et al. Optimization of Blood Pressure Control, Organ Protection and Metabolic Disorders Using a Fixed-dose Combination of Lisinopril+amlodipine+rosuvastatin in Hypertensive Patients After COVID-19. «FIRMA «SILICEA» LLC.